June 1, 2018 · STOCK Act disclosure
Representative Josh Gottheimer (Democrat-NJ) bought Alnylam Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on June 1, 2018 and was disclosed on October 2, 2018 (owner: Joint). Members of Congress must report such transactions within 45 days under the STOCK Act.